6 July 2011

JSC Pharmstandard and DGM Group of Companies announce the establishment of Pharmstandard-Medtechnika LLC

JSC Pharmstandard and DGM Group of Companies announce the establishment of Pharmstandard-Medtechnika LLC
Moscow, 5 July 2011. JSC Pharmstandard and DGM Group of Companies announce the establishment of Pharmstandard-Medtechnika LLC (Pharmstandard-Medtechnika). In order to increase the sales of medical equipment for disinfection and sterilization, Pharmstandard management decided to set up, together with the DGM Group of Companies, a new legal entity, Pharmstandard-Medtechnika LLC (Russia).

JSC Pharmstandard and DGM Group of Companies announce the establishment of Pharmstandard-Medtechnika LLC
JSC Pharmstandard and DGM Trading Limited established Moldido Trading Limited which will be the sole owner of Pharmstandard-Medtechnika LLC. According to the arrangements the parties, the share of Pharmstandard in the project will amount to 75% and that of DGM to 25%. Joint operation will enable JSC Pharmstandard and the DGM Group of Companies to combine their respective expertise for sales of hi-tech Russian medical equipment for disinfection and sterilization. Tyumen Plant of Medical Equipment and Tools (TZMOI), a constituent part of the Pharmstandard Group, is a powerful engineering facility which currently is a clear leader in the domestic market. The DGM Group of Companies has a developed expertise in the area of contract production management and a considerable experience in international transfer of technologies in this sector.

The main objectives of Pharmstandard-Medtechnika LLC include promotion of the full range of equipment for the construction of infection control systems and Central Sterilization Departments within medical establishments, marketing, sales (both direct and through distribution networks), provision of comprehensive services and training for clients. Collaboration of the DGM Group of Companies and JSC Pharmstandard in the field of production of modern domestically-manufactured equipment for the construction of infection control systems and the establishment of the Pharmstandard-Medtechnika Trading Company will lead to the introduction to the market, in near future, of hi-tech, import substituting products which would meet all the requirements and are affordable for Russian medical establishments.

About JSC Pharmstandard:


Pharmstandard is the leader of Russian pharmaceutical industry in R&D and production of the medicinal products. In 2010, Pharmstandard became 2 among all pharmaceutical companies represented in Russia and market share reached 4.2%. Since 2007 Pharmstandard keeps its leading position in commercial segment and remains strong leader among the domestic pharmaceutical company-manufacturers. Pharmstandard became the winner of the national business award "Company of the Year 2010" according to RBC. During the tenth anniversary of «Platinum Ounce 2010», the open competition among professionals of pharma business, Pharmstandard was awarded in the nominations for «The Company of the Year - the Russian pharmaceutical products manufacturer» and «The Company of Decade - the Russian pharmaceutical products manufacturer».

Pharmstandard operates four modern pharmaceutical manufacturing facilities: JSC "Pharmstandard-Leksredstva" in Kursk, JSC "Pharmstandard-UfaVITA" in Ufa, JSC "Pharmstandard-Tomskhimpharm" in Tomsk, PJSC "Pharmstandard-Biolek" in Kharkov (Ukraine) and medical equipment factory JSC "TZMOI" in Tyumen. The Company has invested approximately RUR 3 billion RUR in modernization and development of production capacities reaching more than 1,35 bln units per year. All the production facilities fully comply with Russian manufacturing standards. Six production lines of JSC «Pharmstandard-Leksredstva» meet EU GMP requirements. Pharmstandard portfolio includes over 250 products used in the treatment of diabetes, growth hormone deficiency, cardiovascular diseases, gastroenterological and neurological disorders, infectious diseases, cancer. More than 100 products offered by Pharmstandard are included in the List of Vital and Essential Pharmaceuticals.

Among our market-leading brands are Arbidol®, Complivit®, Pentalgin®, Flucostat®, Phosphogliv®, Amixin® and Afobazol®. Antiviral product «Arbidol» was awarded for «Platinum ounce 2009» in the nominations «OTC Product of the Year» and «OTC Product of Decade». Pentalgin® has been granted "BRAND #1 IN RUSSIA" award for 2009 in analgesics category. In 2004-2010, we developed and introduced over 45 new pharmaceutical products in close collaboration with the leading scientific centers of Russia. Pharmstandard is the partner of the joint venture biotechnological project "Generium" in order to develop and manufacture innovative biological products within the state program of import substitution. Pharmstandard became a public company on 4 may 2007 by offering to the public 27.57% of its share capital in the form of GDR on the London Stock Exchange (LSE) and 18.12% of its share capital in the form of ordinary shares on two local stock exchanges (RTS, MICEX). Approximately 54.31%of voting shares of OJSC "Pharmstandard" are held by "Augment Investments Limited". www.pharmstd.ru.

About DGM Group:

The DGM Group of Companies is a major international al holding with offices in various countries. It specializes in the construction of infection control systems and the manufacturing of equipment for disinfection and sterilization. The Headquarters of DGM is situated in Zug, Switzerland. More than 60% of the Company's business is centered on Russia and the CIS. The development and implementation of the strategy of promotion of the Company's products in the territory of Russia and the CIS was carried out by DGM Pharma Apparate Rus LLC.

The DGM Group of Companies has a cutting-edge expertise in the area of contract production management and operates the most hi-tech manufacturing facilities in the world. Design and construction work, engineering and testing take place in Switzerland, Italy, Poland, China and Russia. The equipment supplied by DGM to the Russian market, is manufactured in Italy, Poland, Hungary and China. The Company's manufacturing and quality control systems, as well as the products themselves, are certified in compliance with the ISO and EU standards. All the DGM sterilization and medical equipment is properly registered in Russia and a number of CIS countries and is designed for exploitation in medical establishments of all types. DGM works with clients who enjoy pragmatic and balanced approach to their choice of equipment and prioritize its long-term and efficient operation. DGM's policy, during the stages of design and promotion of all types of its equipment, is to offer to the clients the most modern equipment and servicing at rational and realistic prices.

Equipment produced by the DGM Group of Companies includes:

• steam sterilizers; • disinfection washing machines; • ultrasonic washing machines; • medical waste sterilizers; • disinfection steam chambers; • CSSD accessories.

DGM equipment is unmatched in terms of its price / quality ratio. The most advanced ideas of leading Russian and European engineers are used for its design and construction. The functionality of the equipment is permanently fine-tuned to suit the requirements of Russian clients. The equipment's energy efficiency, high productivity, reliability and simplicity of operation are combined with its cutting-edge capabilities. DGM provides advanced client support and has its own warehouse in Moscow with a wide range of spare parts to meet its clients needs. DGM infection control systems are successfully employed in medical establishments of various kinds in Russia and the CIS. More than 4000 units of sterilization and disinfection equipments are in operation in the Russian Federation. www.dgm.su.

Back to the list


Zinovev Denis, 23.12.2011 16:22:05
<a href="http://elitavto.com.ua/bus.php"> </a>

To add a comment you need to register first
If you are already registered, please enter the site


Video about ChemRar